Immunomic Therapeutics Contact Us
Immunomic Therapeutics
(301) 968-3501 Add photosOops! Something went wrong, please try again later.
- Website
- Directions
- Appointments
- Contact us
WebHeadquarters & Lab. 15010 Broschart Road Rockville, MD 20850 +1.301.968.3501
See Also: Cell Phone Preview / Show details
Team Immunomic Therapeutics
WebImmunomic Therapeutics, Inc. is committed to building, developing and retaining a world-class team. We are looking for passionate individuals who want to create leading edge …
See Also: Phone Number Preview / Show details
Immunomic Therapeutics, Inc. LinkedIn
WebAbout us. Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted …
See Also: Cell Phone Preview / Show details
Immunomic Therapeutics Crunchbase Company Profile & Funding
WebFounders Teri Heiland, William G. Hearl. Operating Status Active. Last Funding Type Corporate Round. Legal Name Immunomic Therapeutics, Inc. Company Type For …
See Also: Phone Number Preview / Show details
Immunomic Therapeutics: Employee Directory ZoomInfo.com
WebEmployee Directory. Immunomic Therapeutics corporate office is located in 15010 Broschart Rd Ste 250, Rockville, Maryland, 20850, United States and has 74 employees. …
See Also: Office Preview / Show details
Immunomic Therapeutics, Inc Rockville MD Facebook
WebImmunomic Therapeutics, Inc, Rockville, Maryland. 504 likes · 2 talking about this · 10 were here. Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneeri
See Also: Tech Support Preview / Show details
Immunomic Therapeutics Doses First Patient in its Phase 1 Clinical
WebAug 24, 2023 · "Dosing of the first patient in the Phase 1 clinical trial of ITI-1001 in patients with GBM is a significant clinical development milestone for Immunomic, representing …
See Also: Phone Number Preview / Show details
Immunomic Therapeutics Announces First Patient Dosed in Phase I
301-968-3501 WebJul 20, 2022 · Immunomic Therapeutics, Inc. Contacts ITI Company Contact: Melissa Kemp [email protected] 301-968-3501 ITI Media Contact: Melody Carey …
See Also: Contact Support Preview / Show details
Immunomic Therapeutics Announces License Agreement With …
717-327-1822 WebApr 20, 2021 · Company Contact: Sia Anagnostou [email protected] 717-327-1822 Media Contact: Amy Conrad Juniper Point [email protected] 858-366 …
See Also: Contact Support Preview / Show details
Immunomic Therapeutics Company Profile: Valuation, Funding
WebLater Stage VC (Series A) 24-Apr-2014. $6.75M. $14.8M. Completed. Clinical Trials - Phase 2. To view Immunomic Therapeutics’s complete valuation and funding history, request …
See Also: Phone Number Preview / Show details
Immunomic Therapeutics Announces Collaboration With iOncologi
352-559-5100 WebNov 23, 2021 · [email protected]. 352-559-5100. ITI: Melissa Kemp. [email protected]. 301-968-3501. Immunomic Therapeutics, Inc., (“ITI”) a …
See Also: Phone Number Preview / Show details
Immunomic Therapeutics, Inc. Email Format & Employee Directory …
WebGet details for Immunomic Therapeutics, Inc.’s 30 employees, email format for immunomix.com and phone numbers. Immunomic Therapeutics, Inc. (ITI) is a …
See Also: Phone Number Preview / Show details
Immunomic Therapeutics Reports Positive Results from Its Phase 1
WebOct 23, 2023 · Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical-stage biotechnology company pioneering the development of vaccines through its proprietary …
See Also: Tech Support Preview / Show details
Pipeline Immunomic Therapeutics
WebImmunomic Therapeutics’ investigational UNITE® platform is founded in a combination of complementary technologies and capabilities: ITI’s proprietary lysosomal targeting …
See Also: Tech Support Preview / Show details
Immunomic Therapeutics, Inc.: Contact Details and Business …
WebImmunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. Mount Airy, MD, US View. 1 240672XXXX; View Similar People. Related Companies Sucampo Pharmaceuticals, Inc. Get contact …
See Also: Cell Phone Preview / Show details
Immunomic Therapeutics, Inc. Phone, Email, Employees, CEO, VP, …
WebImmunomic Therapeutics, Inc.'s Headquarters are in 15010 Broschart Road Suite 250,Rockville,Maryland,United States What is Immunomic Therapeutics, Inc.'s phone …
See Also: Phone Number Preview / Show details
Immunomic Therapeutics Receives Fast Track Designation for …
WebDec 14, 2022 · Pharmajet partner, Immunomic Therapeutics, received Fast Track Designation from the US Food and Drug Administration (FDA) for a clinical study investigating its plasmid DNA vaccine, ITI-3000, in patients with Merkel cell carcinoma (MCC). 1 The PharmaJet Stratis Needle-free Injection System (NFIS) vaccine was …
See Also: Cell Phone Preview / Show details